Elevance Health (NYSE:ELV – Get Rating) had its target price decreased by analysts at Loop Capital from $565.00 to $550.00 in a report issued on Friday, The Fly reports. Loop Capital’s target price points to a potential upside of 20.90% from the stock’s current price. Several other brokerages have also issued reports on ELV. Wells […]
Elevance Health, Inc. (NYSE:ELV – Get Rating) has been assigned an average recommendation of “Moderate Buy” from the twenty research firms that are covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating on the […]
Elevance Health, Inc. (NYSE:ELV – Get Rating) was the recipient of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 2,080,000 shares, an increase of 50.7% from the February 28th total of 1,380,000 shares. Approximately 0.9% of the company’s shares are sold short. Based […]